Non-executive Chairperson, Nutromics · angel in 1 deal
| Role | Organisation | Sources |
|---|---|---|
| CEO (former) | Cochlear | SmartCompany |
| Non-executive Chairperson | Nutromics | SmartCompany |
| Non-executive Director | ResMed | SmartCompany |
Every published round Dr Chris Roberts took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Atmo Biosciences | undisclosed | 14 Aug 2026 | $12m | Participant | SmartCompany |
Companies Dr Chris Roberts has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Atmo Biosciences | Maker of an ingestible diagnostic capsule for gut conditions | 14 Aug 2026, undisclosed | 1 | 0 |
Fund closes reported for Dr Chris Roberts, as distinct from the investments it has made.
Companies Dr Chris Roberts has backed that another company then bought. An exit for the holding, not a deal Dr Chris Roberts did.
Stories naming Dr Chris Roberts. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Eight Australian and New Zealand startups secured a combined $67.4 million in funding across various sectors including agtech, medtech, robotics, and fintech.
Weekly roundup covering six startup raises: ImmVirX, Nutromics, Nuheara, Autism 360, Cogo and Gather, plus Nutromics' 30X30 selection, a board appointment and Viralytics' earlier sale to Merck.